 |
9 Diseases |  |
1 Trial |
|
1 Trial |  |
136 News |  |
| «12 |
- ||| Dulera (mometasone/formoterol) / Merck (MSD), Novartis
Enrollment closed, Monotherapy: SPIRO: A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241) (clinicaltrials.gov) - Apr 21, 2016
P4, N=11664, Active, not recruiting, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Active, not recruiting
- |||||||||| Dulera (mometasone/formoterol) / Merck (MSD), Novartis
New P3 trial, Combination therapy: Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087) (clinicaltrials.gov) - Apr 18, 2016
P3, N=160, Not yet recruiting, Sponsor: Merck Sharp & Dohme Corp.
- | Dupixent (dupilumab) / Sanofi, Regeneron
Enrollment open: EXPEDITION: Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma (clinicaltrials.gov) - Dec 18, 2015
P2, N=42, Recruiting, Sponsor: Sanofi
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- | Dupixent (dupilumab) / Sanofi, Regeneron
New P2 trial: EXPEDITION: Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma (clinicaltrials.gov) - Oct 22, 2015
P2, N=42, Not yet recruiting, Sponsor: Sanofi
- ||| Dulera (mometasone/formoterol) / Merck (MSD), Novartis
Enrollment open: Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients (clinicaltrials.gov) - Jul 16, 2015
P=N/A, N=66, Recruiting, Sponsor: Mahidol University
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||| Dulera (mometasone/formoterol) / Merck (MSD), Novartis
New trial: Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients (clinicaltrials.gov) - Apr 16, 2015
P=N/A, N=66, Not yet recruiting, Sponsor: Mahidol University
- | Dulera (mometasone/formoterol) / Merck (MSD), Novartis
New P4 trial, Real-world evidence, Adherence, Real-world: Improving Asthma Control in the Real World: A Systematic Approach to Improving Dulera Adherence (clinicaltrials.gov) - Jan 23, 2014
P4, N=40, Recruiting, Sponsor: Asthma Management Systems
- Dulera (mometasone/formoterol) / Merck (MSD), Novartis
Trial withdrawal: Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574) (clinicaltrials.gov) - Dec 22, 2012
P2, N=0, Withdrawn, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Recruiting Completed --> Withdrawn
- Dulera (mometasone/formoterol) / Merck (MSD), Novartis
Enrollment change: Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574) (clinicaltrials.gov) - Nov 12, 2012
P2, N=0, Withdrawn, Sponsor: Merck Sharp & Dohme Corp.
Completed --> Withdrawn N=145 --> 0
- Dulera (mometasone/formoterol) / Merck (MSD), Novartis
Enrollment change: Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212) (clinicaltrials.gov) - Oct 15, 2012
P3, N=49, Completed, Sponsor: Merck
N=145 --> 0 N=40 --> 49
- Dulera (mometasone/formoterol) / Merck (MSD), Novartis
Trial completion: Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212) (clinicaltrials.gov) - Oct 15, 2012
P3, N=49, Completed, Sponsor: Merck
N=40 --> 49 Active, not recruiting --> Completed
- Dulera (mometasone/formoterol) / Merck (MSD), Novartis
New P2 trial: Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574) (clinicaltrials.gov) - Jun 7, 2012
P2, N=0, Withdrawn, Sponsor: Merck Sharp & Dohme Corp.
- Dulera (mometasone/formoterol) / Merck (MSD), Novartis
New P3 trial: Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212) (clinicaltrials.gov) - Mar 27, 2012
P3, N=49, Completed, Sponsor: Merck
- |||| Dulera (mometasone/formoterol) / Merck (MSD), Novartis
Enrollment open, Monotherapy: SPIRO: A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241) (clinicaltrials.gov) - Mar 21, 2012
P4, N=11664, Recruiting, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||| Foradil Aerolizer (formoterol dry powder inhaler) / Novartis
Trial completion, Combination therapy: A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2) (clinicaltrials.gov) - Nov 20, 2011
P2, N=92, Completed, Sponsor: Merck Sharp & Dohme Corp.
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||||| Dulera (mometasone/formoterol) / Merck (MSD), Novartis
New P4 trial, Monotherapy: SPIRO: A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241) (clinicaltrials.gov) - Nov 14, 2011
P4, N=11664, Recruiting, Sponsor: Merck Sharp & Dohme Corp.